##### Table of Contents

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



---

FORM 10-Q



---



|x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ---------------------------------------------------------------------------------------

For the quarterly period ended September 30, 2007.

or



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------------

For the transition period from              to
            .

Commission File Number 333-133319



---

LIFECARE HOLDINGS, INC.

(Exact name of registrant as specified in its charter)



---



|                                                               |  |                                     
|-------------------------------------------------------------- |  | ------------------------------------
|Delaware                                                       |  | 51-0372090                          
|(State or other jurisdiction of incorporation or organization) |  | (IRS Employer Identification Number)
|                                                               | 
|5560 Tennyson Parkway                                          |  | 75024                               
|(Address of Principal Executive Offices)                       |  | (Zip Code)                          

(469) 241-2100

(Registrants telephone number, including area code)

None

(Former name, former address and former fiscal year, if changes since last report)



---

Indicate by check mark whether the
registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.    Yes  x    No ̈

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, or a non-accelerated filer. Please see definition of accelerated and large accelerated filer in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer: ̈Accelerated Filer: ̈Non-Accelerated Filer:  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Act).    Yes ̈No  x

As of November 1, 2007, the registrant had 100 shares of Common Stock, par value $0.01 per share, outstanding.



---



---

##### Table of Contents

LIFECARE HOLDINGS, INC.

TABLE OF CONTENTS



|           |  |                                                                                       |  |   
|---------- |  | ------------------------------------------------------------------------------------- |  | --
|PART I     |  | FINANCIAL INFORMATION                                                                 |  |   
|           |  |                                                                                      
|ITEM 1.    |  | CONSOLIDATED FINANCIAL STATEMENTS                                                     |  | 3 
|           |  |                                                                                      
|           |  | CONDENSED CONSOLIDATED BALANCE SHEETS                                                 |  | 3 
|           |  |                                                                                      
|           |  | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS                                       |  | 4 
|           |  |                                                                                      
|           |  | CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY                             |  | 5 
|           |  |                                                                                      
|           |  | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW                                        |  | 6 
|           |  |                                                                                      
|           |  | NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS                                  |  | 7 
|           |  |                                                                                      
|ITEM 2.    |  | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |  | 14
|           |  |                                                                                      
|ITEM 3.    |  | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK                            |  | 26
|           |  |                                                                                      
|ITEM 4.    |  | CONTROLS AND PROCEDURES                                                               |  | 26
|           |  |                                                                                      
|PART II    |  | OTHER INFORMATION                                                                     |  | 26
|           |  |                                                                                      
|ITEM 1.    |  | LEGAL PROCEEDINGS                                                                     |  | 26
|           |  |                                                                                      
|ITEM 6.    |  | EXHIBITS                                                                              |  | 26
|           | 
|SIGNATURES |  | 27                                                                                   



2



---

##### Table of Contents

PART 1: FINANCIAL INFORMATION



|ITEM 1: | CONSOLIDATED FINANCIAL STATEMENTS
|------- | ---------------------------------

LIFECARE HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

September 30, 2007 (unaudited) and December 31, 2006

(In thousands)



|                                                                                                 |  |                    |          |   |                   |   |          |  
|------------------------------------------------------------------------------------------------ |  | ------------------ | -------- | - | ----------------- | - | -------- | -
|                                                                                                 |  | September 30, 2007 |          |   | December 31, 2006 |  
|Assets                                                                                           |  |                    |          |   |                   |   |          |  
|Cash and cash equivalents                                                                        |  | $                  | 13,571   |   |                   | $ | 33,250   |  
|Accounts receivable, net of allowance for doubtful accounts of $17,215 and $14,400, respectively |  |                    | 70,586   |   |                   |   | 67,464   |  
|Income taxes                                                                                     |  |                    | 8,586    |   |                   |   | 6,418    |  
|Other current assets                                                                             |  |                    | 24,205   |   |                   |   | 17,662   |  
|                                                                                                 |  |                    |          |   |                   |   |          |  
|Total current assets                                                                             |  |                    | 116,948  |   |                   |   | 124,794  |  
|Property and equipment, net                                                                      |  |                    | 78,797   |   |                   |   | 78,418   |  
|Other assets                                                                                     |  |                    | 14,534   |   |                   |   | 14,461   |  
|Identifiable intangibles, net                                                                    |  |                    | 18,731   |   |                   |   | 19,586   |  
|Goodwill                                                                                         |  |                    | 299,159  |   |                   |   | 299,159  |  
|                                                                                                 |  |                    |          |   |                   |   |          |  
|                                                                                                 |  | $                  | 528,169  |   |                   | $ | 536,418  |  
|                                                                                                 |  |                    |          |   |                   |   |          |  
|Liabilities and Stockholders Equity                                                             |  |                    |          |   |                   |   |          |  
|Current installments of long-term debt                                                           |  | $                  | 2,550    |   |                   | $ | 3,188    |  
|Current installments of obligations under capital leases                                         |  |                    | 2,241    |   |                   |   | 3,925    |  
|Estimated third-party payor settlements                                                          |  |                    | 424      |   |                   |   | 8,308    |  
|Accounts payable                                                                                 |  |                    | 32,330   |   |                   |   | 26,905   |  
|Accrued payroll                                                                                  |  |                    | 8,449    |   |                   |   | 6,243    |  
|Accrued vacation                                                                                 |  |                    | 4,118    |   |                   |   | 3,475    |  
|Accrued insurance                                                                                |  |                    | 1,444    |   |                   |   | 1,318    |  
|Accrued interest                                                                                 |  |                    | 2,010    |   |                   |   | 5,295    |  
|Accrued other                                                                                    |  |                    | 4,216    |   |                   |   | 2,110    |  
|                                                                                                 |  |                    |          |   |                   |   |          |  
|Total current liabilities                                                                        |  |                    | 57,782   |   |                   |   | 60,767   |  
|Long-term debt, excluding current installments                                                   |  |                    | 394,350  |   |                   |   | 396,262  |  
|Obligations under capital leases, excluding current installments                                 |  |                    | 770      |   |                   |   | 1,909    |  
|Lease financing obligation                                                                       |  |                    | 12,052   |   |                   |   |         |  
|Accrued insurance                                                                                |  |                    | 6,427    |   |                   |   | 5,902    |  
|Other noncurrent liabilities                                                                     |  |                    | 22,062   |   |                   |   | 21,080   |  
|                                                                                                 |  |                    |          |   |                   |   |          |  
|Total liabilities                                                                                |  |                    | 493,443  |   |                   |   | 485,920  |  
|                                                                                                 |  |                    |          |   |                   |   |          |  
|Commitments and contingencies                                                                    |  |                    |          |   |                   |   |          |  
|                                                                                                 |  |                   
|Stockholders equity:                                                                            |  |                    |          |   |                   |   |          |  
|Common stock, $0.01 par value. 100 shares authorized, issued and outstanding                     |  |                    |         |   |                   |   |         |  
|Additional paid-in capital                                                                       |  |                    | 165,513  |   |                   |   | 161,160  |  
|Accumulated deficit                                                                              |  |                    | (130,787 | ) |                   |   | (110,662 | )
|                                                                                                 |  |                    |          |   |                   |   |          |  
|Total stockholders equity                                                                       |  |                    | 34,726   |   |                   |   | 50,498   |  
|                                                                                                 |  |                    |          |   |                   |   |          |  
|                                                                                                 |  | $                  | 528,169  |   |                   | $ | 536,418  |  
|                                                                                                 |  |                    |          |   |                   |   |          |  

See accompanying notes to condensed consolidated financial statements.



3



---

##### Table of Contents

LIFECARE HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(In thousands)

(Unaudited)



|                                     |  |                                     |         |   |                                     |   |        |                                     |  |   |                                     |   |  |   |         |  
|------------------------------------ |  | ----------------------------------- | ------- | - | ----------------------------------- | - | ------ | ----------------------------------- |  | - | ----------------------------------- | - |  | - | ------- | -
|                                     |  | Three MonthsEnded September 30,2007 |         |   | Three MonthsEnded September 30,2006 |   |        | Nine Months EndedSeptember 30, 2007 |  |   | Nine Months EndedSeptember 30, 2006 |  
|Net patient service revenue          |  | $                                   | 77,553  |   |                                     | $ | 77,437 |                                     |  | $ | 242,475                             |   |  | $ | 246,014 |  
|                                     |  |                                     |         |   |                                     |   |        |                                     |  |   |                                     |   |  |   |         |  
|Salaries, wages, and benefits        |  |                                     | 40,389  |   |                                     |   | 36,224 |                                     |  |   | 117,604                             |   |  |   | 108,575 |  
|Supplies                             |  |                                     | 8,191   |   |                                     |   | 8,027  |                                     |  |   | 24,951                              |   |  |   | 24,863  |  
|Rent                                 |  |                                     | 5,712   |   |                                     |   | 4,714  |                                     |  |   | 15,691                              |   |  |   | 13,539  |  
|Other operating expenses             |  |                                     | 21,180  |   |                                     |   | 19,297 |                                     |  |   | 63,286                              |   |  |   | 60,119  |  
|Provision for doubtful accounts      |  |                                     | 1,404   |   |                                     |   | 1,326  |                                     |  |   | 4,287                               |   |  |   | 4,288   |  
|Depreciation and amortization        |  |                                     | 2,952   |   |                                     |   | 2,948  |                                     |  |   | 8,685                               |   |  |   | 8,802   |  
|Goodwill impairment charge           |  |                                     | 3,834   |   |                                     |   |       |                                     |  |   | 3,834                               |   |  |   | 24,600  |  
|Insurance recovery                   |  |                                     |        |   |                                     |   |       |                                     |  |   |                                    |   |  |   | (5,333  | )
|Interest expense, net                |  |                                     | 8,967   |   |                                     |   | 8,502  |                                     |  |   | 26,466                              |   |  |   | 24,585  |  
|Gain on early extinguishment of debt |  |                                     |        |   |                                     |   |       |                                     |  |   |                                    |   |  |   | (1,329  | )
|                                     |  |                                     |         |   |                                     |   |        |                                     |  |   |                                     |   |  |   |         |  
|Total expenses                       |  |                                     | 92,629  |   |                                     |   | 81,038 |                                     |  |   | 264,804                             |   |  |   | 262,709 |  
|                                     |  |                                     |         |   |                                     |   |        |                                     |  |   |                                     |   |  |   |         |  
|Operating loss                       |  |                                     | (15,076 | ) |                                     |   | (3,601 | )                                   |  |   | (22,329                             | ) |  |   | (16,695 | )
|Equity in loss of joint venture      |  |                                     | (106    | ) |                                     |   |       |                                     |  |   | (448                                | ) |  |   |        |  
|                                     |  |                                     |         |   |                                     |   |        |                                     |  |   |                                     |   |  |   |         |  
|Loss before income taxes             |  |                                     | (15,182 | ) |                                     |   | (3,601 | )                                   |  |   | (22,777                             | ) |  |   | (16,695 | )
|                                     |  |                                     |         |  
|Provision (benefit) for income taxes |  |                                     | (1,953  | ) |                                     |   | (215   | )                                   |  |   | (2,652                              | ) |  |   | 4,509   |  
|                                     |  |                                     |         |   |                                     |   |        |                                     |  |   |                                     |   |  |   |         |  
|Net loss                             |  | $                                   | (13,229 | ) |                                     | $ | (3,386 | )                                   |  | $ | (20,125                             | ) |  | $ | (21,204 | )
|                                     |  |                                     |         |   |                                     |   |        |                                     |  |   |                                     |   |  |   |         |  

See accompanying notes to condensed consolidated financial statements.



4



---

##### Table of Contents

LIFECARE HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders Equity

For the nine months ended September 30, 2007

(In thousands)

(Unaudited)



|                                 |  |              |   |                            |   |                     |  |   |                            |   |  |   |         |  
|-------------------------------- |  | ------------ | - | -------------------------- | - | ------------------- |  | - | -------------------------- | - |  | - | ------- | -
|                                 |  | Common Stock |   | Additional Paid-in Capital |   | Accumulated Deficit |  |   | Total Stockholders Equity |  
|Balance, December 31, 2006       |  | $            |  |                            | $ | 161,160             |  | $ | (110,662                   | ) |  | $ | 50,498  |  
|Equity compensation amortization |  |              |  |                            |   | 519                 |  |   |                           |   |  |   | 519     |  
|Settlement of purchase escrow    |  |              |  |                            |   | 3,834               |  |   |                           |   |  |   | 3,834   |  
|Net loss                         |  |              |  |                            |   |                    |  |   | (20,125                    | ) |  |   | (20,125 | )
|                                 |  |              |   |                            |   |                     |  |   |                            |   |  |   |         |  
|Balance, September 30, 2007      |  | $            |  |                            | $ | 165,513             |  | $ | (130,787                   | ) |  | $ | 34,726  |  
|                                 |  |              |   |                            |   |                     |  |   |                            |   |  |   |         |  

See accompanying notes to condensed consolidated financial statements.



5



---

##### Table of Contents

LIFECARE HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)



|                                                                                          |  |                                    |         |   |                                     |   |         |  
|----------------------------------------------------------------------------------------- |  | ---------------------------------- | ------- | - | ----------------------------------- | - | ------- | -
|                                                                                          |  | Nine MonthsEndedSeptember 30, 2007 |         |   | Nine MonthsEnded September 30, 2006 |  
|Cash flows from operating activities:                                                     |  |                                    |         |   |                                     |   |         |  
|Net loss                                                                                  |  | $                                  | (20,125 | ) |                                     | $ | (21,204 | )
|Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |  |                                    |         |   |                                     |   |         |  
|                                                                                          |  |                                   
|Depreciation and amortization                                                             |  |                                    | 9,865   |   |                                     |   | 9,691   |  
|Provision for doubtful accounts                                                           |  |                                    | 4,287   |   |                                     |   | 4,288   |  
|Impairment charges                                                                        |  |                                    | 3,834   |   |                                     |   | 24,600  |  
|Gain on early extinguishment of debt                                                      |  |                                    |        |   |                                     |   | (1,329  | )
|Equity in losses of joint venture                                                         |  |                                    | 448     |   |                                     |   |        |  
|Deferred income taxes                                                                     |  |                                    | 2,087   |   |                                     |   | (2,933  | )
|Equity compensation amortization                                                          |  |                                    | 519     |   |                                     |   | 467     |  
|Changes in operating assets and liabilities:                                              |  |                                    |         |   |                                     |   |         |  
|Accounts receivable                                                                       |  |                                    | (7,409  | ) |                                     |   | (10,622 | )
|Current income taxes                                                                      |  |                                    | (2,169  | ) |                                     |   | 10,345  |  
|Insurance proceeds receivable                                                             |  |                                    |        |   |                                     |   | 6,212   |  
|Prepaid expenses and other current assets                                                 |  |                                    | (954    | ) |                                     |   | (967    | )
|Other assets                                                                              |  |                                    | (131    | ) |                                     |   | (1,429  | )
|Estimated third-party payor settlements                                                   |  |                                    | (7,884  | ) |                                     |   | 12,209  |  
|Accounts payable and accrued expenses                                                     |  |                                    | 3,322   |   |                                     |   | (398    | )
|Other liabilities                                                                         |  |                                    | 1,509   |   |                                     |   | 6,295   |  
|                                                                                          |  |                                    |         |   |                                     |   |         |  
|Net cash provided by (used in) operating activities                                       |  |                                    | (12,801 | ) |                                     |   | 35,225  |  
|                                                                                          |  |                                    |         |   |                                     |   |         |  
|Cash used in investing activities:                                                        |  |                                    |         |   |                                     |   |         |  
|Purchases of property and equipment                                                       |  |                                    | (37,252 | ) |                                     |   | (16,000 | )
|Sale-leaseback proceeds                                                                   |  |                                    | 26,669  |   |                                     |   | 788     |  
|                                                                                          |  |                                    |         |   |                                     |   |         |  
|Net cash used in investing activities                                                     |  |                                    | (10,583 | ) |                                     |   | (15,212 | )
|                                                                                          |  |                                    |         |   |                                     |   |         |  
|Cash flows used in financing activities:                                                  |  |                                    |         |   |                                     |   |         |  
|Deferred financing cost                                                                   |  |                                    | (1,089  | ) |                                     |   |        |  
|Lease financing obligation proceeds                                                       |  |                                    | 10,466  |   |                                     |   |        |  
|Payments of notes payable and long-term debt                                              |  |                                    | (2,550  | ) |                                     |   | (3,443  | )
|Payments on obligations under capital leases                                              |  |                                    | (3,122  | ) |                                     |   | (4,212  | )
|                                                                                          |  |                                    |         |   |                                     |   |         |  
|Net cash provided by (used in) financing activities                                       |  |                                    | 3,705   |   |                                     |   | (7,655  | )
|                                                                                          |  |                                    |         |   |                                     |   |         |  
|Net increase (decrease) in cash and cash equivalents                                      |  |                                    | (19,679 | ) |                                     |   | 12,358  |  
|Cash and cash equivalents, beginning of period                                            |  |                                    | 33,250  |   |                                     |   | 19,843  |  
|                                                                                          |  |                                    |         |   |                                     |   |         |  
|Cash and cash equivalents, end of period                                                  |  | $                                  | 13,571  |   |                                     | $ | 32,201  |  
|                                                                                          |  |                                    |         |   |                                     |   |         |  
|Supplemental disclosure of cash flow information:                                         |  |                                    |         |   |                                     |   |         |  
|Cash:                                                                                     |  |                                    |         |   |                                     |   |         |  
|Interest paid                                                                             |  | $                                  | 29,751  |   |                                     | $ | 29,684  |  
|Net income taxes received                                                                 |  |                                    | (2,570  | ) |                                     |   | (3,251  | )
|Noncash:                                                                                  |  |                                    |         |   |                                     |   |         |  
|Equipment purchased through capital lease financing                                       |  |                                    | 298     |   |                                     |   |        |  
|Removal of lease financing obligation for facility sale-leaseback                         |  |                                    | 32,759  |   |                                     |   |        |  
|Accrual of purchases of property and equipment                                            |  |                                    | 3,898   |   |                                     |   |        |  
|Accrual of reimbursement due from REIT                                                    |  |                                    | 7,676   |   |                                     |   |        |  

See accompanying notes to condensed consolidated financial statements.



6



---

##### Table of Contents

LifeCare Holdings, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(In thousands, except share and per share data)



|(1) | Basis of Presentation
|--- | ---------------------

LifeCare Holdings, Inc. (the
Company) is a wholly owned subsidiary of LCI Holdco, LLC (Holdco). Holdco is a wholly owned subsidiary of LCI Intermediate Holdco, Inc. (Intermediate Holdco), which is a wholly owned subsidiary of LCI Holding
Company, Inc. (Holdings), which is owned by an investor group that includes affiliates of The Carlyle Group and members of our senior management and board of directors and other minority investors. The investor group acquired Holdings
pursuant to a merger that occurred on August 11, 2005 (the Merger).

The accompanying unaudited condensed consolidated
financial statements and financial information have been prepared in accordance with generally accepted accounting principles, and reflect all adjustments that are, in the opinion of management, necessary for a fair presentation of the results of
the interim periods. The accompanying financial statements for the three and nine month periods ended September 30, 2007 and 2006 are not necessarily indicative of annualized financial results.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated audited financial statements
and notes thereto for the year ended December 31, 2006 included in the Form 10-K filed by us on April 2, 2007 with the Securities and Exchange Commission. Certain information and disclosures normally included in the notes to consolidated
financial statements have been condensed or omitted as permitted by the rules and regulations of the Securities and Exchange Commission, although we believe the disclosure is adequate to make the information presented not misleading.



|(2) | Summary of Significant Accounting Policies
|--- | ------------------------------------------

Use of Estimates

The preparation of the financial statements requires management to make a number of estimates and
assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Actual amounts could differ from those estimates.

Goodwill

We review our goodwill annually, or more frequently if circumstances warrant a more timely review, to determine if there has been an impairment. We review
goodwill based upon one reporting unit. In calculating the fair value of the reporting unit, we use various assumptions including projected cash flows and discount rates. If projected future cash flows decline from the current amounts projected by
management, impairments may be recognized.

We are assessing the financial impact that the Centers for Medicare & Medicaid Services
(CMS) regulations issued on May 1, 2007 and August 1, 2007 will have on our operations. It is possible that the impact may result in recording impairment charges in future periods to the extent the impact affects the carrying value of
goodwill and identifiable intangible assets.

Income Taxes

For the nine months ended September 30, 2007, the income tax benefit recorded is based on the annual effective rate of approximately 14.0%, excluding
the impact of the $3.8 million impairment charge. Based on recent taxable loss trends during the nine months ended September 30, 2007, along with revised projections through December 31, 2007, the federal and state income tax benefit is
less than expected due to the projected need for a valuation allowance on deferred tax assets as of December 31, 2007.

Recent
Accounting Pronouncements

In July 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income
Taxes, an interpretation of FASB Statement 109 (FIN 48). FIN 48 clarifies the accounting for uncertainty in income taxes recognized in an enterprises financial statements and prescribes a threshold of more-likely-than-not for recognition
of tax benefits of uncertain tax positions taken or expected to be taken in a tax return. FIN 48 also provides related guidance on measurement, derecognition, classification, interest and penalties, and disclosure. The provisions of FIN 48 became
effective for us on January 1, 2007. We record accrued interest and penalties associated with uncertain tax positions as income tax expense in the consolidated statement of operations. The adoption of FIN 48 had no impact on our results of
operations and financial position.



7



---

##### Table of Contents

The federal statute of limitations remains open for tax years 2004 through 2006. State jurisdictions
generally have statutes of limitations ranging from three to five years. The state income tax impact of federal income tax changes remains subject to examination by various states for a period up to one year after formal notification to the states.

Reclassifications

Certain reclassifications have been made to the consolidated financial statements for prior periods to conform to the presentation of the 2007 consolidated financial statements, but had no impact on net loss or total stockholders
equity.



|(3) | Net Patient Service Revenue
|--- | ---------------------------

We recognize in the
consolidated financial statements the impact of adjustments, if any, to Medicare reimbursement when the amounts can be reasonably determined. Net revenues for the three months ended September 30, 2007 and 2006 included decreases of $(395) and
$(195), respectively, related to changes in estimates and settlements on prior year cost reports filed with the Medicare program. For the nine months ended September 30, 2007 and 2006, decreases of $(770) and $(3,595), respectively, were
included in net revenues related to changes in estimates and settlements on prior year cost reports filed with the Medicare program.



|(4) | Goodwill and Impairment Charges
|--- | -------------------------------

The Merger
agreement provided for additional purchase price considerations that were contingent upon the resolution of certain specific issues. During the three months ended September 30, 2007, goodwill was increased by $3.8 million due to distributions
to the prior stockholders of our company from the escrow accounts, as the result of the resolution of specific matters. During the nine months ended September 30, 2007, regulatory and industry trends indicate that the value of the Company has
not increased. Therefore, since the increase in goodwill from the above distribution does not add value to the Company and our review as of December 31, 2006 resulted in an impairment to goodwill, we have recorded an impairment charge equal to
the $3.8 million increase to goodwill during the three months ended September 30, 2007.

As a result of the Medicare reimbursement
changes as more fully discussed in note 10 that were effective on July 1, 2006, and our estimate of the impact of the changes on future cash flows, we reviewed the carrying value of our goodwill as of June 30, 2006. As a result of this
review, an impairment charge of $24.6 million was recorded during the three months ended June 30, 2006.

We perform an annual valuation
of goodwill and identifiable intangibles as of December 31 and as otherwise required. The present value of estimated future cash flows is the method used to determine fair value for purposes of these impairment charges. The review to be
performed as of December 31, 2007, could result in additional impairment charges being recorded.



|(5) | Long-Term Debt
|--- | --------------

Long-term debt at
September 30, 2007 consists of the following:



|                                               |  |   |         |  
|---------------------------------------------- |  | - | ------- | -
|Senior secured credit facility - term loan     |  | $ | 249,900 |  
|9 1/4% senior subordinated notes (Notes)     |  |   | 147,000 |  
|                                               |  |   |         |  
|Total long-term debt                           |  |   | 396,900 |  
|Current installments of long-term debt         |  |   | (2,550  | )
|                                               |  |   |         |  
|Long-term debt, excluding current installments |  | $ | 394,350 |  
|                                               |  |   |         |  

The senior secured credit facility consists of (i) a $75 million Revolving Credit Facility,
subject to availability, and (ii) a $249.9 million Term Loan B Facility (Facility).

During the nine months ended
September 30, 2006, we repurchased $3 million of our outstanding Notes for $1.53 million. This resulted in the recording of a $1.33 million gain, net of the write-off of $0.14 million of capitalized financing cost, on the early extinguishment
of this indebtedness.

On May 2, 2007, we entered into Amendment No. 1 for the Facility (Amendment No. 1).
Amendment No. 1 modified certain financial covenants effective March 31, 2007 and increased the spread on the variable interest rate. The applicable margins on the loans as amended are currently (1) 2.25% for alternate base rate
revolving loans, (2) 3.25% for adjusted LIBOR revolving loans, (3) 2.25% for alternate base rate term loans and (4) 3.25% for adjusted LIBOR term loans. These margins are subject to reduction based upon the ratio of our total
indebtedness to our



8



---

##### Table of Contents

consolidated adjusted EBITDA (as defined in the credit agreement governing the Facility and Amendment No. 1 to the credit agreement). We incurred $1.1
million in fees to obtain Amendment No. 1, which have been capitalized and are being amortized over the remaining life of the Facility.

As of September 30, 2007 we were not in compliance with the financial covenant requirements as set forth in the credit agreement for the Facility. However, this event of non-compliance was cured on November 14, 2007 through the exercise of
a cure right as provided for in the credit agreement. The cure right provides us the right to issue permitted cure securities in exchange for cash or otherwise receive cash that would be contributed to our capital in an amount that is necessary to
satisfy the financial covenant requirement on a pro-forma basis. The cure right capital contribution amount is considered additional consolidated EBITDA, as defined in our credit agreement, for purposes of measuring compliance with the financial
covenants for our fiscal quarter ended September 30, 2007. In subsequent periods, this cure amount will continue to be considered a component of consolidated EBITDA on a trailing 4 quarter calculation basis. Additionally, the cure amount is limited
such that it can be no greater than the amount required for purposes of complying with the financial covenants nor can this cure right be exercised more than two times in any trailing 4 quarter period.

The cure right cash contribution necessary to cure our non-compliance with the financial covenants tested as of September 30, 2007, which was $6.0
million, was received by Holdings from affiliates of The Carlyle Group, on November 14, 2007. Holdings in turn contributed these funds to the capital of the Company through certain intermediate subsidiaries. As a result of the exercise of this cure,
we are currently in compliance with the covenants of the credit agreement as amended, and we are deemed to have satisfied the requirements of such financial covenants as of September 30, 2007.

On November 7, 2007, we announced that we would be seeking an amendment to our credit agreement that would address, among other items, future
covenant requirements. There can be no assurance that we will be able to obtain any amendment to our credit agreement on the terms to be proposed by us or at all. If we are able to execute an amendment, it is likely we will incur one-time fees and
expenses, and will be required to pay a higher interest margin on our outstanding indebtedness in subsequent periods.



|(6) | Sale-Leaseback and Lease Financing Obligations
|--- | ----------------------------------------------

On
May 2, 2007, LifeCare REIT 1, Inc. (Tenant), a subsidiary of the Company entered into a Master Lease Agreement (Lease) with Health Care REIT, Inc. and HCRI Texas Properties, LTD (collectively, the Landlord)
in connection with the sale and leaseback of a 62-bed long term acute care hospital being constructed by the Company in San Antonio, Texas (San Antonio Facility). As of June 30, 2007, the San Antonio Facility opened for business, at
which point the operating lease commenced. The base rent is approximately $1.2 million per year, and is subject to annual inflationary adjustments. The inflationary adjustments, which are not to exceed a cumulative average of 0.25% per annum,
are tied to the Medicare long term acute care market basket inflation rate, as determined by the Centers for Medicare and Medicaid Services. As of September 30, 2007, the Landlord had made payments of $13.6 million to the Company towards the
estimated total purchase price of $15.7 million for the San Antonio Facility. No gain will be recognized from this transaction.

On
June 6, 2007, Tenant amended the Master Lease Agreement (Amended Lease) with Health Care REIT, Inc., HCRI Texas Properties, LTD and HCRI Wisconsin Properties, LLC (collectively, the Milwaukee Landlord) to include the
sale and leaseback of a 62-bed long term acute care hospital being constructed by the Company in Milwaukee, Wisconsin (Milwaukee Facility). As of September 24, 2007, the Milwaukee Facility opened for business, at which point the
operating lease commenced. The base rent is approximately $2.5 million per year, and is subject to annual inflation adjustments. The inflationary adjustments, which are not to exceed a cumulative average of



9



---

##### Table of Contents

0.25% per annum, are tied to the Medicare long term acute care market basket inflation rate, as determined by the Centers for Medicare and Medicaid
Services. As of September 30, 2007, the Milwaukee Landlord had made payments of $19.1 million to the Company towards the estimated total purchase price of $25.6 million for the Milwaukee Facility. No gain will be recognized from this
transaction.

The initial term of the leases for these facilities will be 15 years, and the Tenant has one 15-year renewal option. The
initial rent under the Amended Lease will be computed based on a predetermined spread over the rate of a 15-year U.S. Treasury Note and will be subject to an annual inflation adjustment. The Amended Lease is an absolute net lease and
contains customary covenants, representations and warranties. We and our subsidiaries, LifeCare Hospitals of Milwaukee, Inc. and San Antonio Specialty Hospitals, LTD, entered into an Amended and Restated Unconditional and Continuing Lease Guaranty
with the Landlord.

We entered into a separate Master Lease Agreement with Health Care REIT, Inc. on September 1, 2006, to acquire and
develop hospital facilities. The first facility to be developed under this Master Lease is our Boise, Idaho facility, which is currently under construction. The total project cost of this facility is expected to approximate $18.5 million. Through
September 30, 2007, we have incurred capital expenditures of $12.1 million for the facility, and Health Care REIT, Inc. has made payments to us approximating $10.5 million as reimbursement for these capital expenditures. This particular
facility under this Master Lease will be accounted for as a lease financing obligation with the asset remaining capitalized upon completion.



|(7) | Stock Options
|--- | -------------

Successor Stock Option Plan

At September 30, 2007, there were 2.9 million shares of common stock of Holdings available under the 2005 Equity Incentive Plan
(Plan) for stock option grants and other incentive awards, including restricted stock units. Options granted generally have an exercise price equal to the estimated fair value of the shares on the date of grant and expire 10 years from
the date of grant. A restricted stock unit is a contractual right to receive one share of Holdings common stock in the future. Options typically vest one-quarter on each of the first four anniversary dates of the grant and restricted stock units
vest one-quarter upon grant and one-quarter each year thereafter.

Loss for the three and nine months ended September 30, 2007,
includes $194 and $519, respectively, of pre-tax compensation costs related to stock-based compensation arrangements. Loss for the three and nine months ended September 30, 2006, includes $287 and $467, respectively, of pre-tax compensation
costs related to stock-based compensation arrangements.

The following table summarizes stock option activity during the nine months ended
September 30, 2007:



|                              |  |                  |   |  |                                 |     
|----------------------------- |  | ---------------- | - |  | ------------------------------- | ----
|                              |  | Number of Shares |   |  | Weighted average exercise price
|Balance at December 31, 2006  |  | 1,011,000        |   |  | $                               | 6.00
|Granted                       |  |                 |   |  |                                 | 6.00
|Exercised                     |  |                 |   |  |                                 |    
|Forfeited                     |  | (195,000         | ) |  |                                 | 6.00
|Expired                       |  | (15,000          | ) |  |                                 | 6.00
|                              |  |                  |   |  |                                 |     
|Balance at September 30, 2007 |  | 801,000          |   |  | $                               | 6.00
|                              |  |                  |   |  |                                 |     

At September 30, 2007, the weighted average remaining contractual life of outstanding options
was 8.5 years. There were 320,500 stock options exercisable at September 30, 2007. At September 30, 2007, the weighted average exercise price of the vested stock options was $6.00, the remaining weighted average contractual life was 8.2
years. The vested stock option shares at September 30, 2007 had no intrinsic value.

As of September 30, 2007, there was
approximately $1,165 of total unrecognized compensation costs related to stock options. These costs are expected to be recognized over a period of approximately three years.



10



---

##### Table of Contents

Restricted Stock Awards

The following table summarizes restricted stock award activity during the nine months ended September 30, 2007:



|                                  |  |                  |   |  |                                       |     
|--------------------------------- |  | ---------------- | - |  | ------------------------------------- | ----
|                                  |  | Number of Shares |   |  | Weighted Average GrantDate Fair Value
|Number of unvested shares:        |  |                  |   |  |                                       |     
|Outstanding at December 31, 2006  |  | 60,000           |   |  | $                                     | 5.05
|Vested                            |  | (30,000          | ) |  |                                       | 5.05
|Forfeited                         |  | (20,000          | ) |  |                                       | 5.05
|                                  |  |                  |   |  |                                       |     
|Outstanding at September 30, 2007 |  | 10,000           |   |  | $                                     | 5.05
|                                  |  |                  |   |  |                                       |     

One of the holders of restricted stock resigned during 2006. Prior to his resignation, he had
vested in 10,000 restricted shares. During the nine months ended September 30, 2007, Holdings purchased the 10,000 shares that had previously vested for $3.11 per share pursuant to the restricted stock award agreement.

Another holder of restricted stock resigned in August of 2007. Prior to his resignation, he had vested in 60,000 restricted shares. At the time of his
resignation, he had 20,000 unvested shares which were forfeited.

As of September 30, 2007, there was approximately $64 of total
unrecognized compensation costs related to restricted stock awards. These costs are expected to be recognized over a remaining period of approximately one year.



11



---

##### Table of Contents

|(8) | Regulatory Matters
|--- | ------------------

All healthcare providers are
required to comply with a significant number of laws and regulations at the federal and state government levels. These laws are complex, and in many instances, providers do not have the benefit of significant regulatory or judicial interpretation as
to how to interpret and/or apply these laws and regulations. The U.S. Department of Justice and other federal agencies are increasing resources dedicated to regulatory investigations and compliance audits of healthcare providers. As a healthcare
provider, we are subject to these regulatory efforts. Healthcare providers that do not comply with these laws and regulations may be subject to civil or criminal penalties, the loss of their licenses, or restriction in their ability to participate
in various federal and state healthcare programs. We endeavor to conduct our business in compliance with applicable laws and regulations, including healthcare fraud and abuse laws.

We undertake various procedures to assure that our annual cost reports are correctly prepared and filed in accordance with applicable Medicare regulations
governing provider reimbursement. During 2004 and 2003, we conducted an internal review of our previously filed cost reports. As a result of this review, which covered the years 1997 through 2001, we made certain adjustments in 2003 to our
previously reported allowable home office expenses. The findings of this review and proposed amendments to the home office cost reports were submitted to the Office of Inspector General of the Department of Health and Human Services (OIG), which
reviewed our findings. On June 12, 2006, we entered into a Settlement Agreement and a Certification of Compliance Agreement (CCA) with the OIG that settled these matters. The amount paid in connection with this settlement was approximately $2.6
million, which was funded out of a specific escrow account established as part of the Merger that occurred on August 11, 2005. The CCA is effective for three years from the date of the CCA, and requires, among other things, that we continue to
maintain our corporate compliance program, report certain events if they occur to the OIG and file an annual report with the OIG regarding certain specified items, including corporate compliance and internal audit activities.



|(9) | Commitments and Contingencies
|--- | -----------------------------

On
September 28, 2005, the Louisiana Attorney Generals office announced that it was conducting an investigation of 13 nursing homes and six hospitals in the New Orleans area relating to patient deaths that occurred at these facilities during
and in the aftermath of Hurricane Katrina. One of these facilities was Memorial Medical Center within which we operated an 82-bed facility. We have been fully cooperating with this investigation since its inception. On July 18, 2006, the
Attorney Generals office presented certain findings related to this investigation that resulted in the arrest of one physician and two nurses who were not employees of the Company. At the same time, the Attorney General referred its findings
to the New Orleans District Attorney. Neither the Company nor its employees have been named to date in any illegal or criminal activities under investigation by the Attorney General. On February 14, 2007 the New Orleans District Attorney
convened a Grand Jury to determine if any of the three individuals should be indicted and formally charged with criminal acts. On July 24, 2007, the Grand Jury declined to indict the physician in question. It had previously granted immunity to
the two nurses in exchange for their testimony. We cannot determine what, if any, impact this investigation or the Grand Jury proceedings ultimately may have on us.

We are currently defending ourselves against a variety of Katrina related lawsuits or matters under review by the Louisiana Patient Compensation Fund. We are vigorously defending ourselves in these lawsuits, however,
we cannot predict the ultimate resolution of these matters. We maintained $15 million of general and professional liability insurance during this period, subject to a $1 million per claim retention. We believe that under our insurance policies, only
one retention is applicable to the Katrina matters since these matters all arose from a single event, process or condition. Our insurance carriers are currently paying all costs related to these claims, but have sent reservation of rights letters
which challenge, among other things, the application of one retention to the Katrina related matters. To the extent it is ultimately determined that a separate retention applies to each of these claims, we could experience significant losses related
to these Katrina matters which would negatively impact the Companys results of operations.

Significant reductions in the patient
service revenues earned by a hospital may occur if we are unable to maintain the certification of the hospital as an LTACH in accordance with Medicare regulations. Additionally, many of the Companys hospitals operate in space leased from
general acute care hospitals (host hospitals); consequently, these HIH hospitals are subject to additional specific Medicare HIH regulations in addition to the general LTACH regulations. The HIH regulations are designed to ensure that the hospitals
are organizationally and functionally independent of their host hospitals. If an LTACH located in a host hospital fails to meet the HIH regulations, it may also lose its status as an LTACH. The determinations are made on an annual basis.

A provider that loses its ability to receive Medicare payments pursuant to PPS must go through the same certification process as new long-term acute
care hospital providers must go through to obtain their initial certification to be



12



---

##### Table of Contents

reimbursed pursuant to PPS. During this re-certification period, which could range from six to nine months, the provider would be paid for providing services
to Medicare beneficiaries at rates that are lower than rates currently paid pursuant to PPS.

We believe our providers are currently in
compliance with the Medicare regulations regarding HIHs and LTACHs and are expected to maintain compliance under the current Medicare regulations.

During December 2006, we entered into an agreement to form a new joint venture with an unrelated party in the New Orleans market that will own and operate long-term acute care hospitals. During 2007, we contributed to
the joint venture our hospital licenses, Medicare provider numbers and certain remaining equipment from our former New Orleans operations in exchange for a 49.99% ownership in the joint venture. In connection with this joint venture, we guaranteed,
via the issuance of a letter of credit, $0.75 million of a $1.5 million line of credit established by the new joint venture. The joint ventures line of credit is secured by certain assets, including accounts receivable and moveable equipment
of the joint venture, along with our letter of credit. Pursuant to FASB Interpretation No. 45, Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others, we have
established a carrying value $0.25 million associated with this guarantee, which is recorded in other noncurrent liabilities. This value was determined based upon our estimates and probabilities of the likelihood that the operations of this joint
venture would result in us becoming liable under the established letter of credit.

We have certain other pending and threatened litigation
and claims incurred in the ordinary course of business. We (based, in part, on the advice of legal counsel) believe that the probable resolution of such contingencies will not exceed our insurance coverage and will not materially affect the
consolidated financial position, results of operations, or liquidity of the Company.



|(10) | Regulatory Update
|---- | -----------------

On May 1, 2007, CMS issued
changes to the Medicare hospital payment system that are effective for discharges occurring on or after July 1, 2007. The Final Rule was amended on June 29, 2007 by revising the high cost outlier threshold. CMS estimated these changes will
reduce overall payments to LTAC hospitals by 1.2% within the first year of implementation. These changes include: (a) a 0.71% increase to the standard federal payment rate from $38,086 to $38,356; (b) revisions to payment methodologies
impacting short-stay outliers; (c) adjustments to the wage index component of the federal payment; (d) an extension of the policy known as the 25 Percent Rule, to all LTACH hospitals, including those previously exempted due to
a grandfather status, with a three year phase-in, which CMS projects will not result in payment reductions for the first year of implementation but will result in reductions of 2.4% in the second year of implementation; and (e) an
increase in the high-cost outlier fixed-loss threshold amount from $14,887 to $20,738.

The finalized short-stay outlier revisions include
the creation of a new payment category for discharged cases having lengths of stay less than or equal to the geometric mean length of stay for patients with the same diagnosis in short-term acute care hospitals. Payment for these cases would be
similar to that received by a short-term acute care hospital for the same diagnosis.

Currently, CMS has regulations governing payment to
LTAC hospitals that are co-located with another hospital, such as HIHs. Most co-located hospitals can admit up to 25% of its patients from its host hospital and be paid according to LTAC PPS. Admissions that exceed the 25 Percent Rule
are paid using the short-term hospital payment system. Patients reaching high cost outlier status in the short-term hospital are not counted when computing the 25% limit. CMS new rule expands this policy to all LTAC hospitals, regardless of
whether they are co-located with another hospital or were previously grandfathered from this provision. Under the new policy, all LTAC hospitals having fiscal years beginning on or after July 1, 2007 will be paid LTAC PPS rates for
the lesser of admissions from a single referral source up to 75% or the percentage that the LTAC hospital discharged from the referring hospital during the 2005 cost reporting year. Admissions beyond the threshold will be paid using the short-term
hospital payment system. Patients reaching high cost outlier status in the short-term hospital are not counted when computing the threshold. Under the new policy, the threshold will be reduced to the lesser of 50% or the percentage that the LTAC
hospital discharged from the referring hospital during the 2005 cost reporting year for fiscal years beginning on or after July 1, 2008, and will be reduced to 25% for fiscal years beginning on or after July 1, 2009.

CMS also states that the annual update to the DRG classifications and relative weights were made in a budget neutral manner, effective October 1,
2007. As such, the estimated aggregate industry LTAC PPS payments would be unaffected by the annual recalibration of DRG payment weights.



13



---

##### Table of Contents

CMS Changes to DRG Weighting for Fiscal 2008

On August 1, 2007, CMS issued final inpatient prospective payment system (IPPS) regulations for fiscal year 2008. These regulations establish a new
Medicare severity-based patient classification system for fiscal year 2008, called Medicare-Severity DRGs (or MS-DRGs) or MS-LTAC-DRGs for LTAC hospitals. The MS-LTAC-DRG system creates additional severity-adjusted categories for most diagnoses,
resulting in an expansion of the number of DRGs from 538 to 745. CMS states that MS-LTAC-DRG weights were developed in a budget neutral manner and as such, the estimated aggregate payments under LTAC PPS would be unaffected by the annual
recalibration of MS-LTAC-DRG payment weights. CMS has provided for a two year phase-in period to mitigate the transition in payments for IPPS and LTAC PPS providers. In fiscal 2008, provider reimbursements are based 50% on new MS-LTAC-DRGs and 50%
on existing DRGs. For fiscal 2009 100% will be based on new MS-LTAC-DRGs. We are not certain what impact these regulations will have on our operations and financial performance in future periods.



|ITEM 2: | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|------- | -------------------------------------------------------------------------------------

You should read the following discussion and analysis in conjunction with our condensed consolidated financial statements and the accompanying notes.

Company Overview

We are a leading operator of long-term acute care
hospitals (LTACHs) in the United States. As of September 30, 2007 we operated 19 hospitals located in nine states, consisting of 9 hospital within a hospital facilities (31% of beds) and ten freestanding facilities (69%
of beds). Through these 19 long-term acute care hospitals, we operate a total of 1,008 licensed beds and employ approximately 3,100 people, the majority of whom are registered or licensed nurses and respiratory therapists.

We believe we have developed a reputation for excellence in providing treatment for patients with complex medical needs requiring extended treatments. Our patients have
serious medical conditions such as respiratory failure, chronic pulmonary disease, nervous system disorders, infectious diseases and severe wounds. They generally require a high level of monitoring and specialized care yet may not require the
continued services of an intensive care unit. Due to their serious medical conditions, our patients are generally not clinically appropriate for admission to a skilled nursing facility or inpatient rehabilitation facility. By combining general acute
care services with a focus on long-term treatment, we believe that our hospitals provide medically complex patients with better and more cost-effective outcomes.

Recent Trends and Events

Impact of Hurricane Katrina

During December 2006, we entered into an agreement to form a new joint venture with an unrelated party in the New Orleans market that will own and operate long-term acute care hospitals. During 2007, we contributed to
the joint venture our hospital licenses, Medicare provider numbers and certain remaining equipment from our former New Orleans operations in exchange for a 49.99% ownership in the joint venture. During the nine months ended September 30, 2007,
the Company recorded a loss of $448 thousand associated with its share of the joint ventures operating losses.

On September 28, 2005, the
Louisiana Attorney Generals office announced that it was conducting an investigation of 13 nursing homes and six hospitals in the New Orleans area relating to patient deaths that occurred at these facilities during and in the aftermath of
Hurricane Katrina. One of these facilities was Memorial Medical Center within which we operated an 82-bed facility. We have been fully cooperating with this investigation since its inception. On July 18, 2006, the Attorney Generals office
presented certain findings related to this investigation that resulted in the arrest of one physician and two nurses who were not employees of the Company. At the same time, the Attorney General referred its findings to the New Orleans District
Attorney. Neither the Company nor its employees have been named to date in any illegal or criminal activities under investigation by the Attorney General. On February 14, 2007 the New Orleans District Attorney convened a Grand Jury to determine
if any of the three individual should be indicted and formally charged with criminal acts. On July 24, 2007, the Grand Jury declined to indict the physician in question. It had previously granted immunity to the two nurses in exchange for their
testimony. We cannot determine what, if any, impact this investigation or the Grand Jury proceedings ultimately may have on us.

We are currently defending
ourselves against a variety of Katrina related lawsuits or matters under review by the Louisiana Patient Compensation Fund. We are vigorously defending ourselves in these lawsuits, however, we cannot predict the ultimate resolution of these matters.
We maintained $15 million of general and professional liability insurance during this period, subject to a $1 million per claim retention. We believe that under our insurance policies, only one retention is



14



---

##### Table of Contents

applicable to the Katrina matters since these matters all arose from a single event, process or condition. Our insurance carriers are currently paying all
costs related to these claims, but have sent reservation of rights letters which challenge, among other things, the application of one retention to the Katrina related matters. To the extent it is ultimately determined that a separate retention
applies to each of these claims, the Company could experience significant losses related to these Katrina matters which would negatively impact our results of operations.

Hospital Openings and Closings

In July 2006, we closed a 40-bed hospital within a hospital in Edinburgh,
Texas. We opened a 24-bed satellite hospital within a hospital in Shreveport, Louisiana during August 2006 and a 41-bed satellite hospital within a hospital in Pittsburgh, Pennsylvania in September 2006. We expanded an existing hospital in
Shreveport, Louisiana by seven beds in November 2006, and opened a satellite 32-bed freestanding hospital in McAllen, Texas in December 2006. The licensed beds at the Shreveport locations were transferred internally among total licensed beds in the
Shreveport market; therefore, there was no change in total beds as a result of these openings during 2006.

During the first quarter of 2007, we terminated
the lease at the Doctors Hospital campus in Shreveport, Louisiana. Seven beds were transferred to another location and the 12 beds remaining at this location were closed. Eight beds were added to our Denver, Colorado location during the same period.
In June 2007, we opened a 62-bed freestanding hospital in San Antonio, Texas, which replaced a 34-bed hospital within a hospital in San Antonio that was closed in the same month. In August 2007, 20 beds were added to our Denver location. In
September 2007, we opened a 62-bed freestanding hospital in Milwaukee, Wisconsin, which replaced a 35-bed hospital within a hospital in Milwaukee that was closed in the same month.

The assets formerly located in our hospitals that were closed or relocated are being used at other locations or were disposed of.

Regulatory Changes

Approximately 64.3% and 71.5% of our total net patient service revenue for the nine months
ended September 30, 2007 and 2006, respectively, came from Medicare reimbursement. In addition, an increasing number of our non-Medicare patients are paid under methodologies similar to those used by Medicare. Our industry is subject to
extensive government regulation, including regulation of the Medicare reimbursement process. Changes in these regulations can have a material impact on the way we operate our business and on our results of operations. In recent years, several
material changes in reimbursement regulations have been implemented including the 25% limit on admissions from a host hospital to an HIH, and the re-weighting of LTACH diagnosis related groupings, or DRGs. In addition CMS has issued changes to
fiscal 2008 Medicare reimbursement, that may significantly reduce our Medicare reimbursement. CMS is also considering establishing new patient and facility criteria for long-term acute care hospital providers.

Medicare Reimbursement Change in Payment Rate for Fiscal 2007

On
May 2, 2006 CMS issued the final regulations for the 2007 fiscal year which began on July 1, 2006 relating to the prospective payment system for LTACHs. The final rules, among other things, (i) changed the payment provisions related
to short-stay outliers; (ii) increased the outlier fixed-loss amount from $10,501 to $14,887; (iii) increased the labor-related share of the prospective payment system federal rate from 72.855% to 75.665%; (iv) eliminated the surgical
case exception to the three-day or less interruption of stay policy; and (v) froze the fiscal 2007 federal rate at the 2006 level.

Prior to the
regulations, the payment methodology for short-stay outliers reimbursed long-term acute care hospital providers at the lowest of (i) 120% of patient cost; (ii) 120% of the per diem amount based on the diagnosis related group; or
(iii) the full diagnosis related group payment. The CMS changes to short-stay outliers reimbursement added a fourth payment alternative, a blended amount based upon (i) the amount that would otherwise be paid under the short-term acute
care inpatient: (iv) a blend of an amount comparable to what would otherwise be paid under the short-term acute care inpatient payment system (IPPS DRG) computed as a per diem and capped at the full IPPS DRG comparable payment
amount, and (ii) 120% of the per diem amount based on the DRG for long-term acute care hospitals. An additional CMS change lowered the reimbursement under the patient cost payment alternative from 120% of patient cost to 100%.

CMS estimated that exclusive of the freeze of the federal rate for fiscal 2007, these changes resulted in a decrease in Medicare reimbursement of 3.7% for LTACH
providers.

CMS Changes to DRG Weighting for Fiscal 2007

On August 1, 2006, CMS issued changes to the Medicare hospital payment system, including changes to the relative weights and lengths of stay for the diagnosis related groups treated by LTACHs. This final rule was effective for Medicare
discharges on or after October 1, 2006. CMS estimated these changes would result in reduced payments to LTAC providers by 1.3% based on the current reimbursement regulations that were in place. This reduction was in addition to the reduction
discussed previously as a result of the fiscal 2007 rule changes. Historically, the actual impact of regulation changes on our Medicare net patient service revenue has closely approximated CMSs estimates. The actual impact of these
reimbursement changes in subsequent periods could be materially different from CMSs estimate.



15



---

##### Table of Contents

The final regulations also included (1) changes in the regulations applicable to grandfathered
hospitals-within-hospitals and grandfathered satellite facilities, and (2) changes in the methodology for determining cost-to-charge ratios for LTACHs and the reconciliation of high-cost and short-stay outlier payments under the Medicare
payment system for such hospitals.

Medicare Reimbursement Changes for Fiscal 2008

On May 1, 2007, CMS issued changes to the Medicare hospital payment system that will become effective for discharges occurring on or after July 1, 2007. The Final Rule was amended on June 29, 2007 by
revising the high cost outlier threshold. CMS estimates these changes will reduce overall payments to LTAC hospitals by 1.2% in the first year of implementation. These changes include: (a) a 0.71% increase to the standard federal payment rate
from $38,086 to $38,356; (b) revisions to payment methodologies impacting short-stay outliers; (c) adjustments to the wage index component of the federal payment; (d) an extension of the policy known as the 25 Percent Rule
to all LTACH hospitals, including those previously exempted due to a grandfather status, with a three year phase-in, which CMS projects will not result in payment reductions for the first year of implementation; and (e) an increase
in the high-cost outlier fixed-loss threshold amount from $14,887 to $20,738.

The finalized short-stay outlier revisions include the creation of a new
payment category for discharged cases having lengths of stay less than or equal to the geometric mean length of stay for patients with the same diagnosis in short-term acute care hospitals. Payment for these cases would be similar to that received
by a short-term acute care hospital for the same diagnosis.

Currently, CMS has regulations governing payment to LTAC hospitals that are co-located with
another hospital, such as HIHs. Most co-located hospitals can admit up to 25% of its patients from its host hospital and be paid according to LTAC PPS. Admissions that exceed the 25 Percent Rule are paid using the short-term hospital
payment system. Patients reaching high cost outlier status in the short-term hospital are not counted when computing the 25% limit. CMS new rule expands this policy to all LTAC hospitals, regardless of whether they are co-located with another
hospital or were previously grandfathered from this provision. Under the new policy, all LTAC hospitals having fiscal years beginning on or after July 1, 2007 will be paid LTAC PPS rates for the lesser of admissions from a single
referral source up to 75% or the percentage that the LTAC hospital discharged from the referring hospital during the 2005 cost reporting period. Admissions beyond the threshold will be paid using the short-term hospital payment system. Patients
reaching high cost outlier status in the short-term hospital are not counted when computing the threshold. Under the new policy, the threshold will be reduced to the lesser of 50% or the percentage that the LTAC hospital discharged from the
referring hospital during the 2005 cost reporting period for fiscal years beginning on or after July 1, 2008, and will be reduced to 25% for fiscal years beginning on or after July 1, 2009.

CMS also states that the annual update to the DRG classifications and relative weights were made in a budget neutral manner, effective October 1, 2007. As such, the
estimated aggregate industry LTAC PPS payments would be unaffected by the annual recalibration of DRG payment weights.

We believe that the new policy will
reduce our Medicare reimbursement. While we will attempt to mitigate the effect of these changes, there can be no guarantee that such efforts will be successful.

CMS Changes to DRG Weighting for Fiscal 2008

On August 1, 2007, CMS issued final inpatient prospective payment system (IPPS)
regulations for fiscal year 2008. These regulations establish a new Medicare severity-based patient classification system for fiscal year 2008, called the Medicare-Severity DRGs (or MS-DRGs) or MS-LTAC-DRGs for LTAC hospitals. The MS-LTAC-DRG system
creates additional severity-adjusted categories for most diagnoses, resulting in an expansion of the number of DRGs from 538 to 745. CMS states that MS-LTAC-DRG weights were developed in a budget neutral manner and as such, the estimated aggregate
payments under LTAC PPS would be unaffected by the annual recalibration of MS-LTAC-DRG payment weights. CMS has provided for a two year phase-in period to mitigate the transition in payments for IPPS and LTAC PPS providers. In fiscal 2008, provider
reimbursements are based 50% on new MS-LTAC-DRGs and 50% on existing DRGs. For fiscal 2009 100% will be based on new MS-LTAC-DRGs. We are not certain what impact these regulations will have on our operations and financial performance in future
periods.



16



---

##### Table of Contents

CMS Study on Patient and Facility Criteria

Based upon a June 2004 report prepared by MedPAC, it was recommended that CMS study and consider new patient and facility criteria for long-term acute care hospital providers. The contractor commissioned by CMS to
conduct aspects of this analysis submitted its report to CMS in December 2006. At this time we are not certain as to what actions CMS may take as a result of this study nor of the impact any such proposed changes, if adopted, could have on our
operations and financial performance in future periods.

Regulatory Matters

In 2003, we conducted an internal review of previously filed cost reports for the years 1997-2001. As a result of that review, proposed amendments to home office cost reports were submitted to the Office of Inspector
General of the Department of Health & Human Services (OIG). As discussed in note 16 to our December 31, 2006 consolidated financial statements included in our Form 10-K filed with the SEC on April 2, 2007, we
entered into a Settlement Agreement and a Certification of Compliance Agreement (CCA) with the OIG that settled these matters on June 12, 2006. The amount paid in connection with this settlement was approximately $2.6 million, which was funded
out of a specific escrow account established as part of the Merger that occurred on August 11, 2005. The CCA is effective for three years from the date of the CCA, and requires, among other things, that we continue to maintain our corporate
compliance program, report certain events if they occur to the OIG and that we file an annual report with the OIG regarding our corporate compliance program. We believe that the annual incremental costs to comply with the CCA will not be significant
since we currently maintain an active corporate compliance program.

Sources of Revenue

We are reimbursed for our services provided to patients by a number of sources, including the federal Medicare program and commercial payors. Payment arrangements include
prospectively determined rates per discharge, reimbursed costs, discounted charges and per diem rates. Our net patient service revenue consists of the amounts that we estimate to be reimbursable from each of the applicable non-governmental payors
and the Medicare and Medicaid programs. We account for the differences between the estimated reimbursement rates and our standard billing rates as contractual adjustments, which are deducted from gross revenues to arrive at net revenues. We record
accounts receivable resulting from such payment arrangements net of contractual allowances. Net patient service revenues generated directly from the Medicare program approximated 64.3% and 71.5% of total net patient service revenue for the nine
months ended September 30, 2007 and 2006, respectively. Net patient service revenues generated from non-Medicare payors were generally from commercial payors. However, an increasing number of our non-Medicare patients are paid under
methodologies similar to those used by Medicare.

Laws and regulations governing provider reimbursement pursuant to the Medicare program are
complex and subject to interpretation. The Medicare reimbursement amounts reported in our financial statements are based upon estimates and, as such, are subject to adjustment until such time as our billings and cost reports are filed and settled
with the appropriate regulatory authorities. Federal regulations require that providers participating in the Medicare program submit annual cost reports associated with services provided to program beneficiaries. In addition, payments under LTACH
PPS are subject to review by the regulatory authorities. These reviews primarily focus on the accuracy of the DRG assigned to each discharged patient and normally occur after the completion of the billing process.

The annual cost reports are also subject to review and adjustment by CMS through its fiscal intermediaries. These reviews may not occur until several years after a
provider files its cost reports and often results in adjustments to amounts reported by providers in their cost reports as a result of the complexity of the regulations and the inherent judgment that is required in the application of certain
provisions of provider reimbursement regulations. Since these reviews of filed cost reports occur periodically, there is a possibility that recorded estimated Medicare reimbursement reflected in our consolidated financial statements and previously
filed cost reports may change by a material amount in future periods. We recognize in our consolidated financial statements the impact of adjustments, if any, to estimated Medicare reimbursement when the amounts can be reasonably determined. Net
revenues for the three months ended September 30, 2007 and 2006, included decreases of $(395) and $(195), respectively, and decreases of $(770) and $(3,595), for the nine months ended September 30, 2007 and 2006, respectively, related to
changes in estimates and settlements on prior year cost reports filed with the Medicare program. The most significant cost report valuation adjustment recognized during the nine month period ended September 30, 2006 related to two of our
hospitals. In these cases, the actual cost to charge ratio, which is used to determine the reimbursement for short stay and high cost outliers, was outside the 10% limit of the cost to charge ratio amount used by CMS to process interim claims and
therefore resulted in a reconciliation of payments to the actual cost to charge ratio for these cost report periods.



17



---

##### Table of Contents

Total Expenses

Total
expenses consists of salaries, wages and benefits, supplies, which includes expenses related to drug and medical supplies, rent, other operating expenses, provision for doubtful accounts, depreciation and amortization and interest expense. Other
operating expenses include expenses such as contract labor, legal and accounting fees, insurance and contracted services purchased from host hospitals.

Other Operating Metrics

We use certain operating metrics in the management of our facility operations. These include:

Licensed beds. Licensed beds represent beds for which a facility has been granted approval to operate from the applicable state licensing agency. These licensed
beds are used in the determination of average licensed beds and occupancy rates.

Average licensed beds. We compute average licensed beds by
computing a weighted average based upon the number of licensed beds in place for each month within the reporting period.

Admissions. Admissions are
the total number of patients admitted to our facilities during the reporting period.

Patient days. Patient days are the cumulative number of days
that licensed beds are occupied in our facilities for the entire reporting period. We also refer to patient days as our census.

Average length of stay
(days). We compute average length of stay in days by dividing patient days for discharged patients by discharges.

Occupancy rates. We compute
our occupancy rate by determining the percentage of average licensed beds that are occupied for a 24-hour period during a reporting period. The occupancy rate provides a measure of the utilization of inpatient rooms.

Net patient service revenue per patient day. This measure is determined by dividing our total net patient service revenue by the number of patient days in a
reporting period. We use this metric to provide a measure of the net patient service revenue generated for each patient day.

Critical Accounting
Matters

This discussion and analysis of our financial condition and results of operation is based on our consolidated financial statements, which have
been prepared in accordance with accounting principles generally accepted in the United States. The preparation of those financial statements requires the use of estimates and judgments that affect the reported amounts and related disclosures. We
rely on historical experience and other assumptions that we believe are reasonable at the time in forming the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual
amounts may differ from these estimates.

We believe that the following critical accounting policies as more fully described in our annual financial
statements as of December 31, 2006 as filed in the Form 10-K, affect the more significant judgments and estimates used in the preparation of our consolidated financial statements.



| |  |  | Revenue recognition
| | - |  | -------------------



| |  |  | Accounts receivable and allowance for doubtful accounts
| | - |  | -------------------------------------------------------



| |  |  | Insurance Risks
| | - |  | ---------------



| |  |  | Impairment of Long-Lived Assets
| | - |  | -------------------------------



| |  |  | Accounting for income taxes
| | - |  | ---------------------------



| |  |  | Accounting for stock-based compensation
| | - |  | ---------------------------------------

Goodwill

We review our goodwill annually, or more frequently, if circumstances warrant a more timely review, to determine if there
has been an impairment. We review goodwill based upon one reporting unit. In calculating the fair value of the reporting unit, we use various assumptions including projected cash flows and discount rates. If projected future cash flows decline from
the current amounts projected by management, impairments may occur, which would be recognized in our financial statements.

The Merger agreement provided
for additional purchase price considerations that were contingent upon the resolution of certain specific issues. During the three months ended September 30, 2007, goodwill was increased by $3.8 million due to



18



---

##### Table of Contents

distributions to the prior stockholders of our company from the escrow accounts, as the result of the resolution of specific matters. During the nine months
ended September 30, 2007, regulatory and industry trends indicate that the value of the Company has not increased. Therefore, since the increase in goodwill from the above distribution does not add value to the Company and our review as of
December 31, 2006 resulted in an impairment to goodwill, we have recorded an impairment charge equal to the $3.8 million increase to goodwill during the three months ended September 30, 2007.

As a result of the Medicare reimbursement changes, as previously discussed, that were effective on July 1, 2006, and our estimate of the impact of the changes on
future cash flows, we reviewed the carrying value of our goodwill as of June 30, 2006. As a result of this review, an impairment charge of $24.6 million was recorded during the three months ended June 30, 2006.

We are assessing the financial impact that the final regulations issued on May 1, 2007 and August 1, 2007 will have on our operations. It is possible that the
actual impact may result in recording impairment charges in future periods as it relates to the carrying value of goodwill and identifiable intangible assets.

Results of Operations

The following table sets forth operations for each of the periods presented.



|                                     |  |                                |         |   |                                |   |        |      |  |   |         |   |  |   |         |  
|------------------------------------ |  | ------------------------------ | ------- | - | ------------------------------ | - | ------ | ---- |  | - | ------- | - |  | - | ------- | -
|                                     |  | Three Months EndedSeptember 30 |         |   | Nine Months Ended September 30 |  
|                                     |  | 2007                           |         |   | 2006                           |   |        | 2007 |  |   | 2006    |  
|Net patient service revenue          |  | $                              | 77,553  |   |                                | $ | 77,437 |      |  | $ | 242,475 |   |  | $ | 246,014 |  
|Salaries, wages and benefits         |  |                                | 40,389  |   |                                |   | 36,224 |      |  |   | 117,604 |   |  |   | 108,575 |  
|Supplies                             |  |                                | 8,191   |   |                                |   | 8,027  |      |  |   | 24,951  |   |  |   | 24,863  |  
|Rent                                 |  |                                | 5,712   |   |                                |   | 4,714  |      |  |   | 15,691  |   |  |   | 13,539  |  
|Other operating expenses             |  |                                | 21,180  |   |                                |   | 19,297 |      |  |   | 63,286  |   |  |   | 60,119  |  
|Provision for doubtful accounts      |  |                                | 1,404   |   |                                |   | 1,326  |      |  |   | 4,287   |   |  |   | 4,288   |  
|Depreciation and amortization        |  |                                | 2,952   |   |                                |   | 2,948  |      |  |   | 8,685   |   |  |   | 8,802   |  
|Goodwill impairment charges          |  |                                | 3,834   |   |                                |   |       |      |  |   | 3,834   |   |  |   | 24,600  |  
|Insurance recovery                   |  |                                |        |   |                                |   |       |      |  |   |        |   |  |   | (5,333  | )
|Interest expense, net                |  |                                | 8,967   |   |                                |   | 8,502  |      |  |   | 26,466  |   |  |   | 24,585  |  
|Gain on early extinguishment of debt |  |                                |        |   |                                |   |       |      |  |   |        |   |  |   | (1,329  | )
|                                     |  |                                |         |   |                                |   |        |      |  |   |         |   |  |   |         |  
|Total expenses                       |  |                                | 92,629  |   |                                |   | 81,038 |      |  |   | 264,804 |   |  |   | 262,709 |  
|                                     |  |                                |         |   |                                |   |        |      |  |   |         |   |  |   |         |  
|Operating loss                       |  |                                | (15,076 | ) |                                |   | (3,601 | )    |  |   | (22,329 | ) |  |   | (16,695 | )
|Equity in loss of joint venture      |  |                                | (106    | ) |                                |   |       |      |  |   | (448    | ) |  |   |        |  
|                                     |  |                                |         |   |                                |   |        |      |  |   |         |   |  |   |         |  
|Loss before income taxes             |  |                                | (15,182 | ) |                                |   | (3,601 | )    |  |   | (22,777 | ) |  |   | (16,695 | )
|Provision (benefit) for income taxes |  |                                | (1,953  | ) |                                |   | (215   | )    |  |   | (2,652  | ) |  |   | 4,509   |  
|                                     |  |                                |         |   |                                |   |        |      |  |   |         |   |  |   |         |  
|Net loss                             |  | $                              | (13,229 | ) |                                | $ | (3,386 | )    |  | $ | (20,125 | ) |  | $ | (21,204 | )
|                                     |  |                                |         |   |                                |   |        |      |  |   |         |   |  |   |         |  

Operating Statistics

The following table sets forth operating statistics for each of the periods presented.



|                                                                            |  |                                |        |   |                                |   |        |      |  |   |         |   |  |   |         |  
|--------------------------------------------------------------------------- |  | ------------------------------ | ------ | - | ------------------------------ | - | ------ | ---- |  | - | ------- | - |  | - | ------- | -
|                                                                            |  | Three Months EndedSeptember 30 |        |   | Nine Months Ended September 30 |  
|                                                                            |  | 2007                           |        |   | 2006                           |   |        | 2007 |  |   | 2006    |  
|Number of hospitals within hospitals (end of period)                        |  |                                | 9      |   |                                |   | 13     |      |  |   | 9       |   |  |   | 13      |  
|Number of freestanding hospitals (end of period)                            |  |                                | 10     |   |                                |   | 6      |      |  |   | 10      |   |  |   | 6       |  
|Number of total hospitals (end of period)                                   |  |                                | 19     |   |                                |   | 19     |      |  |   | 19      |   |  |   | 19      |  
|Licensed beds (end of period) (1)                                           |  |                                | 1,008  |   |                                |   | 894    |      |  |   | 1,008   |   |  |   | 894     |  
|Average licensed beds (1)                                                   |  |                                | 976    |   |                                |   | 867    |      |  |   | 944     |   |  |   | 884     |  
|Admissions                                                                  |  |                                | 1,972  |   |                                |   | 2,033  |      |  |   | 5,868   |   |  |   | 6,219   |  
|Patient days                                                                |  |                                | 55,616 |   |                                |   | 55,327 |      |  |   | 172,042 |   |  |   | 170,453 |  
|Occupancy rate                                                              |  |                                | 61.9   | % |                                |   | 69.4   | %    |  |   | 66.8    | % |  |   | 70.6    | %
|Percent net patient service revenue from Medicare                           |  |                                | 60.3   | % |                                |   | 72.0   | %    |  |   | 64.3    | % |  |   | 71.5    | %
|Percent net patient service revenue from commercial payors and Medicaid (2) |  |                                | 39.7   | % |                                |   | 28.0   | %    |  |   | 35.7    | % |  |   | 28.5    | %
|Net patient service revenue per patient day                                 |  | $                              | 1,394  |   |                                | $ | 1,400  |      |  | $ | 1,409   |   |  | $ | 1,443   |  



19



---

##### Table of Contents

---

|(1) | The licensed beds are only calculated on the beds at locations that were open for operations during the applicable period, and exclude beds at locations prior to openings, or
subsequent to closures.
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(2) | The percentage of net patient service revenue from Medicaid is less than one percent for each of the periods presented.
|--- | -----------------------------------------------------------------------------------------------------------------------

Overview

During the first quarter of 2007, we terminated the
lease at the Doctors Hospital campus in Shreveport, Louisiana. Seven beds were transferred to another location and the 12 beds remaining at this location were closed. Eight beds were added to our Denver, Colorado location during the same period. In
June 2007, we opened a 62-bed freestanding hospital in San Antonio, Texas, which replaced a 34-bed hospital within a hospital in San Antonio that was closed in the same month. In August 2007, 20 beds were added to our Denver location. In September
2007, we opened a 62-bed freestanding hospital in Milwaukee, Wisconsin, which replaced a 35-bed hospital within a hospital in Milwaukee that was closed in the same month. The new beds added in the current quarter have caused our occupancy rate to
decrease for the three months ended September 30, 2007 as compared to the same period in 2006.

During July 2006, we closed a 40-bed hospital within a
hospital in Edinburgh, Texas. We opened a 24-bed satellite hospital within a hospital in Shreveport, Louisiana during August 2006 and a 41-bed satellite hospital within a hospital in Pittsburgh, Pennsylvania during September 2006. We expanded an
existing hospital in Shreveport, Louisiana by seven beds in November 2006, and opened a satellite 32-bed freestanding hospital in McAllen, Texas during December 2006. The licensed beds at the Shreveport locations were transferred internally among
total licensed beds in the Shreveport market; therefore, there was no change in total beds in Shreveport.

Three Months Ended September 30, 2007
Compared to Three Months Ended September 30, 2006

Net Revenues

Our net patient service revenue of $77.6 million for the three months ended September 30, 2007, increased by $0.1 million as compared to the same period in 2006. Patient days increased by 289 during the 2007
period. During the three months ended September 30, 2007, our net patient service revenue per patient day was $1,394 as compared to $1,400 per patient day for the same period in 2006, which represents a decrease of 0.4%. This decrease on a per
patient day basis was primarily the result of the recent unfavorable reimbursement changes implemented by CMS as discussed previously.

Total
Expenses

Total expenses increased by $11.6 million to $92.6 million for the three months ended September 30, 2007 as compared to $81.0 million
for the comparable period in 2006. Of this $11.6 million increase in total expenses, $3.8 million related to goodwill impairment charges and $2.5 million was attributable to compensation and benefits accrued in connection with the departure of the
CEO during the three months ended September 30, 2007. Rent expense increased by $1.0 million during the 2007 period in connection with the increases in bed capacity as discussed previously. Net interest expense increased by $0.4 million during
the 2007 period from an increase in LIBOR rates and the increased margin spread as the result of the amendment to our senior secured credit facility discussed further in the Liquidity and Capital Resources section contained herein. The remaining
unfavorable variance of $3.9 million was related to increases in salaries, wages and benefits, supplies, outside services and contract labor expenses incurred as the result of inflationary increases and the increases in bed capacity as previously
discussed.

Income Tax Expense

For the three
months ended September 30, 2007, the 12.9% income tax benefit recorded is based on an annual effective rate of approximately 14.0%, excluding the impact of the $3.8 million impairment charges, as compared to an effective rate of 6% for the same
period in 2006. Based on recent taxable loss trends during the three months ended September 30, 2007 along with revised projections through December 31, 2007, a federal and state income tax benefit is less than expected due to the
projected need for a valuation allowance on deferred tax assets as of December 31, 2007.



20



---

##### Table of Contents

Nine Months Ended September 30, 2007 Compared to Nine Months Ended September 30, 2006

Net Revenues

Our net patient service revenue decreased by
$3.5 million, or 1.4%, for the nine months ended September 30, 2007, to $242.5 million from $246.0 million for the comparable period in 2006. Patient days in 2007 were 1,589 greater, or 0.9% greater, than the same period in 2006.

This decrease in net patient service revenue was comprised of a $2.3 million favorable benefit from an increase in patient days and an unfavorable $8.6 million variance
as the result of decreased revenue per patient day, offset by a net increase of $2.8 million attributable to a decrease in unfavorable adjustments related to previously filed cost reports. This increase in patient days was partially attributable to
the expansion of our operations, as discussed previously.

During the nine months ended September 30, 2007 and 2006, we recorded reductions in net
patient service revenue of $0.7 million and $3.6 million, respectively, related to changes in estimates and settlements on cost reports filed with the Medicare program. The adjustment recognized during the nine months ended September 30, 2006
related to two of the Companys hospitals. In these cases, the actual cost to charge ratio, which is used to determine the reimbursement for short stay and high cost outliers, was outside the 10% limit of the cost to charge ratio amount used by
CMS to process interim claims such that it resulted in a reconciliation of payments to the actual cost to charge ratio for these cost report periods.

Our
net patient service revenue per patient day as reported during the nine months ended September 30, 2007 and 2006, was $1,409 and $1,443, respectively. However, exclusive of the cost report reimbursement adjustments discussed previously, net
patient service revenue per patient day for the nine months ended September 30, 2007 and 2006 was $1,414 and $1,464, respectively. The decrease in net patient service revenue per patient day, excluding the impact of the cost report
reimbursement adjustment, was primarily the result of the unfavorable reimbursement changes implemented by CMS for all discharges on or after July 1, 2006 and the unfavorable reduction in DRG weights for all discharges on or after
October 1, 2006, partially offset by an increase in the percentage of our revenues generated from commercial payors and our continued focus on treating higher acuity patients.

Total Expenses

Total expenses decreased by $2.1 million to $264.8 million for the nine months ended
September 30, 2007 as compared to $262.7 million for the comparable period in 2006. Included in the expenses for the nine month period ending September 30, 2007, is a $3.8 million impairment charge related to goodwill and $2.5 million
attributable to compensation and benefits accrued in connection with the departure of the CEO during the three months ended September 30, 2007, as discussed previously. Included in the expenses for the 2006 period is an impairment charge of
$24.6 million related to goodwill as discussed previously, a gain of $1.3 million related to the early extinguishment of debt, and $5.3 million in insurance recovery related to Hurricane Katrina. Gain on early extinguishment of debt for the nine
months ended September 30, 2006 was the result of our repurchasing $3 million in face of our senior subordinated notes for an amount approximating $1.5 million. Partially offsetting the gain was the write-off of capitalized financing cost of
$0.1 million recorded in connection with the retirement of these senior subordinated notes.

Excluding the impairment charge and the compensation and
benefits accrual for 2007, and the impairment charge, gain on early extinguishment of debt, and the insurance recovery for 2006, expenses increased by $13.7 million from the same period in prior year. Rent expenses increased by $2.1 million during
the 2007 period in connection with the increases in bed capacity as discussed previously. Net interest expense increased by $1.9 million during the 2007 period from an increase in LIBOR rates and the increased margin spread as the result of the
amendment to our senior secured credit facility discussed further in the Liquidity and Capital Resources section contained herein. The remaining $9.7 million increase in expenses was primarily attributable to an increase in salaries, wages and
benefits of $6.5 million, and an increase in outside services, contract labor and other operating expenses of $3.2 million. These increases were due to the result of inflationary increases and the increases in bed capacity as previously discussed.

Income Tax Expense

For the nine months ended
September 30, 2007, we recorded income tax benefit of $2.7 million which represented an annual effective rate of approximately 14.0%, excluding the impact of the $3.8 million impairment charge, as compared to an income tax expense of $4.5
million for the same period in 2006, which represented an effective rate of 55%, excluding the impact of the $24.6 million impairment charges and certain other adjustments. As discussed previously, the federal and state income tax benefit is less
than expected due to the projected need for a valuation allowance on deferred tax assets as of December 31, 2007.



21



---

##### Table of Contents

Liquidity and Capital Resources

Although operating cash flows for the nine months ending September 30, 2007 were negative, our primary sources of liquidity are cash on hand, expected cash flows generated by operations, potential availability of
borrowings under a revolving credit facility, and funds available under the Master Lease. Our primary liquidity requirements are for debt service on our senior secured credit facilities and the notes, capital expenditures and working capital.

At September 30, 2007, our debt structure consisted of $147.0 million aggregate principal amount of senior subordinated notes, a senior secured
credit facility, consisting of a $249.9 million term loan facility, which matures on August 11, 2012, and a $75.0 million revolving credit facility subject to availability, including sub-facilities for letters of credit and swingline loans, which
matures on August 11, 2011. The full amount available under the term loan facility was used in connection with the Merger. During the nine months ended September 30, 2006 we repurchased $3 million face value of our senior subordinated notes for
approximately $1.5 million. Accordingly, we recorded a gain on early extinguishment of debt, net of write-off of capitalized financing costs, of approximately $1.3 million during this period.

The senior secured credit facility requires us to comply on a quarterly basis with certain financial covenants, including an interest coverage ratio test and a maximum
leverage ratio test, which will become more restrictive over time. In addition, the senior secured credit facility includes various negative covenants, including limitations on indebtedness, liens, investments, permitted businesses, restricted
payments, transactions with affiliates and other matters, as well as certain customary representations and warranties, affirmative covenants and events of default including payment defaults, breach of representations and warranties, covenant
defaults, cross defaults to certain indebtedness, certain events of bankruptcy, certain events under ERISA, material judgments, actual or asserted failure of any guaranty or security document supporting the senior secured credit facility to be in
full force and effect, change of control, and certain other provisions.

On May 2, 2007, we entered into Amendment No. 1 for the senior secured
credit facility (Amendment No. 1). Amendment No. 1 modified certain financial covenants effective March 31, 2007 and increased the spread on the variable interest rate to be paid by the Company. Based upon amounts
presently outstanding under the senior secured credit facility and current interest rates, Amendment No. 1 will result in an increase in annual interest expense of approximately $1.9 million.

The interest rates per annum applicable to loans, other than swingline loans, under our senior secured credit facility are, at our option, equal to either an alternate
base rate or an adjusted LIBOR rate for a one-, two-, three- or six-month interest period, or a nine- or twelve-month period if available, in each case, plus an applicable margin. The applicable margins on the loans as amended are currently
(1) 2.25% for alternate base rate revolving loans, (2) 3.25% for adjusted LIBOR revolving loans, (3) 2.25% for alternate base rate term loans, and (4) 3.25% for adjusted LIBOR term loans. These margins are subject to reduction
based upon the ratio of our total indebtedness to our consolidated adjusted EBITDA (as defined in the credit agreement governing our senior secured credit facility and Amendment Number 1 to the credit agreement). At September 30, 2007, the
interest rate applicable to the $249.9 million under our term loan facility was 8.20%.

As of September 30, 2007 we were not in compliance with the
financial covenant requirements as set forth in the credit agreement for the Facility. However, this event of non-compliance was cured on November 14, 2007 through the exercise of a cure right as provided for in the credit agreement. The cure right
provides us the right to issue permitted cure securities in exchange for cash or otherwise receive cash that would be contributed to our capital in an amount that is necessary to satisfy the financial covenant requirement on a pro-forma basis. The
cure right capital contribution amount is considered additional consolidated EBITDA, as defined in our credit agreement, for purposes of measuring compliance with the financial covenants for our fiscal quarter ended September 30, 2007. In subsequent
periods, this cure amount will continue to be considered a component of consolidated EBITDA on a trailing 4 quarter calculation basis. Additionally, the cure amount is limited such that it can be no greater than the amount required for purposes of
complying with the financial covenants nor can this cure right be exercised more than two times in any trailing 4 quarter period.

The cure right cash
contribution necessary to cure our non-compliance with the financial covenants tested as of September 30, 2007, which was $6.0 million, was received by Holdings from affiliates of The Carlyle Group, on November 14, 2007. Holdings in turn contributed
these funds to the capital of the Company through certain intermediate subsidiaries. As a result of the exercise of this cure, we are currently in compliance with the covenants of the credit agreement as amended, and we are deemed to have satisfied
the requirements of such financial covenants as of September 30, 2007.



22



---

##### Table of Contents

On November 7, 2007, we announced that we would be seeking an amendment to our credit agreement that would address,
among other items, future covenant requirements. There can be no assurance that we will be able to obtain any amendment to our credit agreement on the terms to be proposed by us or at all. If we are able to execute an amendment, it is likely we will
incur one-time fees and expenses, and will be required to pay a higher interest margin on our outstanding indebtedness in subsequent periods.

We may not
be able to continue to satisfy the covenant requirements in subsequent periods. If we are unable to maintain compliance with the covenants contained in our senior secured credit facility, an event of default would occur. During the continuance of an
event of a default, the lenders under the senior secured credit facility are entitled to take various actions, including accelerating amounts due under the senior secured credit facility, terminating our access to our revolving credit facility and
all other actions permitted to be taken by a secured creditor. An event of default could have a material adverse effect on our financial position, results of operations and cash flow.

We believe that our cash on hand, expected cash flows from operations, potential availability of borrowings under the revolving portion of our senior secured credit facilities, and funds available under the Master
Lease will be sufficient to finance our operations, and meet our scheduled debt service requirements for at least the next twelve months.

On May 2,
2007, LifeCare REIT 1, Inc. (Tenant), a subsidiary of the Company entered into a Master Lease Agreement (Lease) with Health Care REIT, Inc. and HCRI Texas Properties, LTD (collectively, the Landlord) in connection
with the sale and leaseback of a 62-bed long term acute care hospital being constructed by the Company in San Antonio, Texas (San Antonio Facility). As of Sept 30, 2007, the San Antonio Facility opened for business, at which point
the operational lease commenced. The base rent is approximately $1.2 million per year, and is subject to annual inflationary adjustments. The inflationary adjustments, which are not to exceed a cumulative average of 0.25% per annum, are tied to
the Medicare long term acute care market basket inflation rate, as determined by the Centers for Medicare and Medicaid Services. As of September 30, 2007, the Landlord had made payments of $13.6 million to the Company towards the estimated
total purchase price of $15.7 million for the San Antonio Facility. No gain will be recognized from this transaction.

On June 6, 2007, Tenant amended
the Master Lease Agreement (Amended Lease) with Health Care REIT, Inc., HCRI Texas Properties, LTD and HCRI Wisconsin Properties, LLC (collectively, the Milwaukee Landlord) to include the sale and leaseback of a 62-bed long
term acute care hospital being constructed by the Company in Milwaukee, Wisconsin (Milwaukee Facility). The base rent is approximately $2.5 million per year, and is subject to annual inflation adjustments. The inflationary adjustments,
which are not to exceed a cumulative average of 0.25% per annum, are tied to the Medicare long term acute care market basket inflation rate, as determined by the Centers for Medicare and Medicaid Services. As of September 30, 2007, the
Milwaukee Landlord had made payments of $19.1 million to the Company towards the estimated total purchase price of $25.6 million for the Milwaukee Facility. No gain will be recognized from this transaction.

The initial term of the leases for these facilities will be 15 years, and the Tenant has one 15-year renewal option. The initial rent under the Amended Lease will be
computed based on a predetermined spread over the rate of a 15-year U.S. Treasury Note and will be subject to an annual inflation adjustment. The Lease is an absolute net lease and contains customary covenants, representations and
warranties. The Company and its subsidiary, LifeCare Hospitals of Milwaukee, Inc. and San Antonio Specialty Hospitals, LTD, entered into an Amended and Restated Unconditional and Continuing Lease Guaranty with the Landlord.

We entered into a separate Master Lease Agreement with Health Care REIT, Inc. on September 1, 2006, to acquire and develop hospital facilities. The first facility
to be developed under this Master Lease is our Boise, Idaho facility, which is currently under construction. The total project cost of this facility is expected to approximate $18.5 million. Through September 30, 2007, we have incurred capital
expenditure of $12.1 million for the facility, and Health Care REIT, Inc. has made payments to us approximating $10.5 million as reimbursement for these capital expenditures. This particular facility under this Master Lease will be accounted for as
a lease financing obligation with the asset remaining capitalized upon completion.



23



---

##### Table of Contents

Capital Expenditures

We anticipate that we may incur capital expenditures of approximately $4.5 million during the remainder of 2007 based on our current plans. These expenditures will relate to the transition plans for facilities affected by the new 25% host
hospital admission threshold regulations, market expansion opportunities, investment in information technology enhancements, and facility maintenance requirements.

Historical Cash Flow

Nine Months Ended September 30, 2007 and 2006



|                                                    |  |                               |         |   |      |   |         |  
|--------------------------------------------------- |  | ----------------------------- | ------- | - | ---- | - | ------- | -
|                                                    |  | Nine Months EndedSeptember 30 |        
|                                                    |  | 2007                          |         |   | 2006 |  
|Net cash provided by (used in) operating activities |  | $                             | (12,801 | ) |      | $ | 35,225  |  
|Net cash used in investing activities               |  |                               | (10,583 | ) |      |   | (15,212 | )
|Net cash provided by (used in) financing activities |  |                               | 3,705   |   |      |   | (7,655  | )

For the nine months ended September 30, 2007, cash used in operating activities was $12.8 million as compared
to providing $35.2 million in cash for the comparable period in 2006. For the nine-months ended September 30, 2007, we had a net loss of $20.1 million as compared to a net loss of $21.2 million for the same period in 2006. The net loss for the
2007 period included a $3.8 million impairment charge and the net loss for the 2006 period included a $24.6 million impairment charge. Excluding these impairment charges, the net income for the 2007 period decreased by $19.7 million to a loss of
$16.3 million from net income of $3.4 million in the 2006 period. Additionally, during the nine months ended September 30, 2006 we received $12.4 million related to a refund of 2005 federal income tax payments. This tax benefit was the result
of expenses recorded related to the Merger during the year ended December 31, 2005. During the nine months ended September 30, 2006, we also received $7.0 million in business interruption proceeds as a result of the impact of Hurricane
Katrina on our New Orleans operations.

Accounts receivable increased by $7.4 million for the nine months ended September 30, 2007, as compared to an
increase of $10.6 million for same period during 2006. Days of net patient service revenue in accounts receivable at September 30, 2007 had increased to 84.5, as compared to 77.1 at December 31, 2006. Additionally, estimated third-party
payor settlements increased by $7.9 million during the nine-months ended September 30, 2007 as compared to a decrease of $12.2 million during the 2006 period. As disclosed previously, we converted to a new patient accounting system during the
fourth quarter of 2006 and we began to centralize certain medical records coding functions during 2007. These activities, which we believe will result in overall better management of our accounts receivable process as well as decrease our overall
accounts receivable, have resulted in short-term increases in accounts receivable during 2007 as we complete the implementation of these initiatives. The changes during the 2006 period were primarily the result of a 9-day claims processing hold by
CMS for all providers effective for the final 9-days of September 2006, in addition to the timing of periodic interim payments we receive from Medicare.

Cash used in investing activities was $10.6 million and $15.2 million for the nine months ended September 30, 2007 and 2006, respectively. During the 2007 period, we received $26.7 million of proceeds related to the lease agreement
entered into with Health Care REIT, Inc. associated with our San Antonio, Texas, and Milwaukee, Wisconsin facilities as discussed previously.

Cash
provided by financing activities for the nine months ended September 30, 2007 was $3.7 million as compared to cash used of $7.7 million for the same period in 2006. During the 2007 period, proceeds of $10.5 million were received from Health
Care REIT, Inc. for capital expenditures associated with our development project in Boise, Idaho. Additionally, $1.1 million was used for financing costs associated with the senior secured credit facility amendment as previously discussed. Included
in the $7.7 million for the 2006 period was $1.5 million that was used to repurchase $3 million in face value of our senior subordinated notes.

Seasonality

Our business experiences seasonality resulting in variation in census levels, with the highest census historically occurring in
the first quarter of the year and the lowest census occurring in the third quarter of the year.



24



---

##### Table of Contents

Inflation

We derive
a substantial portion of our revenue from the Medicare program. LTACH PPS payments are subject to fixed payments that generally are adjusted annually for inflation. However, there can be no assurance that these adjustments, if received, will reflect
the actual increase in our costs for providing healthcare services. As discussed previously, the final rules issued by CMS for LTACHs for the 2007 fiscal year did not provide for an inflation update.

Labor and supply expenses make up a substantial portion of our operating expense structure. The expenses can be subject to increase in periods of rising inflation. To
date, we have been able to offset such increases with corresponding increases in reimbursement and the implementation of cost control measures. There can, however, be no assurance that we will be successful in offsetting future cost increases.

Forward Looking Statements

This quarterly report
contains forward-looking statements regarding, among other things, our financial condition, results of operations, plans, objectives, future performance and business. All statements contained in this document other than historical information are
forward-looking statements. Forward-looking statements include, but are not limited to, statements that represent our beliefs concerning future operations, strategies, financial results or other developments, and contain words and phrases such as
may, expects, believes, anticipates, estimates, should, or similar expressions. Because these forward-looking statements are based on estimates and assumptions that are subject
to significant business, economic and competitive uncertainties, many of which are beyond our control or are subject to change, actual results could be materially different. Although we believe that our plans, intentions and expectations reflected
in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and
assumptions. Important factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to:



| |  |  | changes in government reimbursement for our services may have an adverse effect on our future revenues and profitability including, for example, the changes
described under Regulatory Changes;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the failure to maintain compliance with our covenants could be costly or have a material adverse effect on us;
| | - |  | --------------------------------------------------------------------------------------------------------------



| |  |  | the amount of outstanding indebtedness and the restrictive covenants in the agreements governing our indebtedness may limit our operating and financial flexibility;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | a government investigation or assertion that we have violated applicable regulations may result in increased costs or sanctions that reduce our revenues and
profitability;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | actions that may be brought by individuals on the governments behalf under the False Claims Acts qui tam or whistleblower provisions may
expose us to unforeseen liabilities;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the failure of our long-term acute care hospitals to maintain their qualification could cause our revenues and profitability to decline;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the adoption by Medicare of new restrictive criteria regarding the types of patients that may be admitted to our facilities or new payment methods for long-term
acute care hospitals may cause our revenues and profitability to decline;
| | - |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the failure of our satellite facilities to qualify for provider-based status with the applicable main facilities may adversely affect our
results of operations;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | implementation of new information systems to comply with federal and state initiatives relating to patient privacy, security of medical information and electronic
transactions may result in increased costs;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | integration of recently acquired operations and future acquisitions may prove difficult or unsuccessful, use significant resources or expose us to unforeseen
liabilities;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | private third-party payors for our services may undertake future cost containment initiatives that limit our future revenues and profitability;
| | - |  | -----------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | an increase in uninsured and underinsured patients in our hospitals or the deterioration in the collectibility of the accounts of such patients could harm our
results of operations;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the failure to maintain established relationships with the physicians in our markets could reduce our revenues and profitability;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------



| |  |  | shortages in qualified nurses or therapists could increase our operating costs significantly;
| | - |  | ---------------------------------------------------------------------------------------------



| |  |  | competition may limit our ability to grow and result in a decrease in our revenues and profitability;
| | - |  | -----------------------------------------------------------------------------------------------------



| |  |  | the loss of key members of our management team could significantly disrupt our operations;
| | - |  | ------------------------------------------------------------------------------------------



25



---

##### Table of Contents

| |  |  | the geographic concentration of our facilities in Texas may make us sensitive to economic, regulatory, environmental and other developments in this state;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Adverse changes in individual markets could significantly affect operating results;
| | - |  | -----------------------------------------------------------------------------------



| |  |  | the effect of legal actions or other claims associated with the Louisiana Attorney Generals investigation or other circumstances arising from Hurricane
Katrina could subject us to substantial liabilities, and;
| | - |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the effect of legal actions asserted against us or lack of adequate available insurance could subject us to substantial uninsured liabilities.
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------

Consequently, such forward-looking statements should be regarded solely as our current plans, estimates and beliefs. We do not intend,
and do not undertake, any obligation to update any forward-looking statements to reflect future events or circumstances after the date of this report.



|ITEM 3: | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|------- | ----------------------------------------------------------

At
September 30, 2007, we had $249.9 million in senior term loans outstanding and a $75.0 million revolving credit facility, which is subject to availability, each bearing interest at variable rates. Each 0.125% point change in interest rates
would result in a $0.4 million annual change in interest expense on our term loans and revolving credit facility loans, assuming that our revolving credit facility is fully drawn. Pursuant to our senior term loan credit agreement we were required to
enter into an interest rate Swap Agreement that would provide protection against fluctuations in interest rates on a notional amount of $12 million. On November 9, 2005, we entered into such an agreement for a three year period. This agreement
will cap the LIBOR rate used to compute interest on the notional amount of our senior term loan at six percent per annum. In the future, we may enter into additional interest rate swaps, involving exchange of floating for fixed rate interest
payments, to reduce interest rate volatility.



|ITEM 4: | CONTROLS AND PROCEDURES
|------- | -----------------------

We carried out an evaluation, under the
supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities
Exchange Act of 1934) as of the end of the period covered in this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures provide reasonable assurance
that material information required to be included in our periodic SEC reports is recorded, processed, summarized and reported within the time periods specified in the relevant SEC rules and forms.

In addition, we reviewed our internal controls, and there have been no significant changes in our internal controls or in other factors that could significantly affect
those controls in the third quarter.

PART II: OTHER INFORMATION



|ITEM 1: | LEGAL PROCEEDINGS
|------- | -----------------

The Company is a party to various legal actions
that arise in the ordinary course of business, as well as other litigation described elsewhere in this report. These actions are primarily related to malpractice claims covered under insurance policies; however, there may be some legal actions which
are not insured. The Company is unable to predict the ultimate outcome of pending litigation and regulatory and other government investigations, nor can there be any assurance that the resolution of any litigation or investigation, either
individually or in the aggregate, would not have a material adverse effect on the Companys financial position, results of operations or liquidity.



|ITEM 6: | EXHIBITS
|------- | --------

The exhibits to this report are listed in the Exhibit
Index appearing on page 31 hereof.



26



---

##### Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.



LifeCare Holdings, Inc.By:

/s/ WILLIAM HAMBURGWilliam HamburgChief Executive OfficerBy:

/s/ PHILLIP B. DOUGLASPhillip B. DouglasChief Financial Officer


Dated: November 14, 2007



27



---

##### Table of Contents

EXHIBIT INDEX



|        |  |                                                                                                                                                                               
|------- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Exhibit |  | Description                                                                                                                                                                   
|31.1    |  | Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|        | 
|31.2    |  | Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|        | 
|32.1    |  | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                            
|        | 
|32.2    |  | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                            



28